FDA Advisory No.2024-0196 || Safety Information: Domperidone and increased risk of serious ventricular arrhythmia
Domperidone is a dopamine antagonist with pro-kinetic, antiemetic properties. Studies have shown that oral domperidone increases lower esophageal pressure, improves antraduodenal motility and accelerates gastric emptying. There is no effect […]
FDA Advisory No.2024-0030 || Bupivacaine and Reports of Failed or Incomplete Spinal Anesthesia
Introduction The Food and Drug Administration (FDA) collated a series of reports of lack of efficacy associated with the drug products containing Bupivacaine due to increasing reports of failed or […]
FDA Advisory No.2023-2596-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na beripikadong pekeng gamot: 1. Ibuprofen + Paracetamol (Alaxan®FR) 200 mg/ 325 mg […]
FDA Advisory No.2023-2596 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:
The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the following products: 1. Ibuprofen + Paracetamol (Alaxan®FR) 200 mg/ 325 […]
FDA Advisory No.2023-2595 || Public Health Warning on Substandard (Contaminated) Pediatric Drug Products in Syrup and Suspension Dosage Forms Confirmed by the World Health Organization (WHO)
The Food and Drug Administration (FDA) notifies the public on the WHO Medical Product Alert on five (5) substandard (contaminated) pediatric drug products manufactured (as stated in label) by Pharmix […]
FDA Advisory No.2023-2594-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na beripikadong pekeng gamot: 1. Paracetamol (Biogesic®) 500 mg Tablet 2. Phenylephrine Hydrochloride […]
FDA Advisory No.2023-2594 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:
The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the following products: 1. Paracetamol (Biogesic®) 500 mg Tablet 2. Phenylephrine […]
FDA Advisory No.2023-2528-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Kanerga® Amoxicillin Capsules 0.25 g x 36”
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot na: 1. Kanerga® Amoxicillin Capsules 0.25 g x 36 Napatunayan sa pamamagitan […]
FDA Advisory No.2023-2528 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Kanerga® Amoxicillin Capsules 0.25 g x 36”
The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: 1. Kanerga® Amoxicillin Capsules 0.25 g x 36 FDA Post-Marketing Surveillance […]
FDA Advisory No.2023-2529 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Dahongying Meloxicam Tablets 7.5 mg”
The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: 1. Dahongying Meloxicam Tablets 7.5 mg FDA Post-Marketing Surveillance (PMS) activities […]